Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,515,861
+$1,389,441 QoQ
Shares Held
232,138
+439.9% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 111 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. ACHV ranks #203 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in ACHV

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,515,861 232,138
2026-03-31 $126,420 43,000
2025-12-31 $99,400 20,000
2025-03-31 $239,130 89,562
2024-12-31 $315,258 89,562
2024-09-30 $424,523 89,562
2024-06-30 $450,664 95,886
2022-03-31 $78,016 10,306